Education
About Us
Working with TipRanks
Follow Us
Atossa Therapeutics (ATOS)
NASDAQ:ATOS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -17.00K | $ -23.00K | $ -8.00K | $ -23.00K | $ -46.60K |
| Operating Income | $ -27.62M | $ -31.38M | $ -27.69M | $ -20.52M | $ -14.61M |
| EBITDA | $ -25.49M | $ -31.35M | $ -27.68M | $ -20.50M | $ -14.56M |
| Net Income | $ -25.50M | $ -30.09M | $ -26.23M | $ -20.61M | $ -21.10M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 71.08M | $ 88.46M | $ 110.89M | $ 136.38M | $ 39.55M |
| Total Assets | $ 76.44M | $ 96.25M | $ 123.53M | $ 141.26M | $ 42.84M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 18.05K |
| Net Debt | $ -71.08M | $ -88.46M | $ -110.89M | $ -136.38M | $ -39.54M |
| Total Liabilities | $ 4.97M | $ 5.24M | $ 5.57M | $ 3.13M | $ 15.67M |
| Stockholders' Equity | $ 71.48M | $ 91.02M | $ 117.96M | $ 138.14M | $ 27.17M |
| Cash Flow | |||||
| Free Cash Flow | $ -21.05M | $ -20.95K | $ -20.79M | $ -16.48M | $ -11.58M |
| Operating Cash Flow | $ -21.03M | $ -20.94K | $ -20.76M | $ -16.47M | $ -11.57M |
| Investing Cash Flow | $ -19.00K | $ -14.00 | $ -4.73M | $ -9.00K | $ -9.37K |
| Financing Cash Flow | $ 3.67M | $ -1.48K | $ 0.00 | $ 113.30M | $ 38.55M |